BarclayHedge: Hedge Funds Up 9.84% Through Nov.

Dec 20 2013 | 1:19pm ET

Hedge funds won't have much to celebrate this holiday season, according to one industry index.

The Barclay Hedge Fund Index rose just 0.71% in November, far behind the Standard & Poor's 500 Index's 2.8% jump last month. For the year, the numbers are no better: With just a month to go, the Barclay benchmark is in striking distance of double-digits at 9.84%—but the S&P500 was up 26% through November.

Sixteen of the 18 strategies tracked by BarclayHedge were in the black last month, led by healthcare and biotechnology, up 3.05% (25.66% year-to-date). "In spite of a dismal launch that raised concerns about Obamacare's longer-term success, healthcare was the top-performing sector in November as well as year-to-date," BarclayHedge founder Sol Waksman said.

Distressed securities funds added an average of 1.71% in November (15.89% YTD), global macro 1.68%, equity long-bias 1.55% (19.23% YTD), European equities 1.37% and Pacific Rim equities 1.24% (20.63% YTD).

Equity short-bias has had as bad a year as healthcare has enjoyed a good: The strategy is down 25.32% after dropping 2.01% last month; the result is worse even than its record loss last year of 24.12%. Emerging markets funds also lost ground in November, falling 0.53%.

The Barclay Fund of Funds Index rose 1.01% on the month (7.22% YTD).


In Depth

Q&A: Old Hill's Stone On Private Debt, P2P And Credit Bubbles

Jun 6 2017 | 7:52pm ET

While institutional capital continues to flow into the broader private debt sector...

Lifestyle

CFA Institute To Add Computer Science To Exam Curriculum

May 24 2017 | 9:25pm ET

Starting in 2019, financial industry executives sitting for the coveted Chartered...

Guest Contributor

Steinbrugge: Asia-Focused Hedge Funds Offer Great Opportunities

Jun 23 2017 | 3:33pm ET

Emerging market strategies have outperformed their developed-market peers for five...

 

From the current issue of